- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Alliance Imaging posts loss in 1994
Mobile MRI chain Alliance Imaging posted a $19 million loss as part of its 1994 annual results,based largely on a non-recurring $13.8 million charge in the fourthquarter. The charge was related to a write-down of assets andrepresents the completion of
Mobile MRI chain Alliance Imaging posted a $19 million loss as part of its 1994 annual results,based largely on a non-recurring $13.8 million charge in the fourthquarter. The charge was related to a write-down of assets andrepresents the completion of Alliance's restructuring plan, accordingto president and CEO Richard Zehner.
For the year, Alliance, of Orange, CA, had revenues of $57.9million, down 4.7% from the $60.7 million posted in 1993. Fourthquarter revenues rose 3.5%, however, to $14.9 million from $14.4million in the fourth quarter of 1993. The $19 million net losscompares to a $14.7 million net loss for the same period the yearbefore. Alliance completed a restructuring of its debt load latelast year (SCAN 12/28/94).
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
